Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Intervalo de año de publicación
1.
Rev. chil. nutr ; 46(5): 633-643, oct. 2019.
Artículo en Español | LILACS | ID: biblio-1042705

RESUMEN

Durante los primeros meses de vida, los oligosacáridos de la leche materna (HMOs) aportados por la leche materna participan en procesos asociados con la maduración de tejidos y sistemas del tubo digestivo, modulan algunos de sus procesos metabólicos y ejercen efectos prebióticos y antimicrobianos. Otros efectos estudiados son su contribución a la instalación, desarrollo y estimulación de la microbiota residente con predomino de Bifidobacterium y Bacteroides, con efectos protectores frente a posibles colonizaciones o patologías por enteropatógenos (bacterianas, virus o parásitarias) que pueden actuar nivel local en el tubo digestivo, pero también pueden influir a nivel sistémico. Los HMOs modularían el desarrollo de la inmunidad innata y adaptativa, y probablemente previenen el desarrollo de fenómenos de atopia/alergia. Una patología propia de la etapa neonatal de los prematuros es la enterocolitis necrosante y algunos HMOs podrían disminuir el riesgo de su manifestación. Las actividades de los oligosacáridos de la leche materna contribuyen a la adaptación del lactante a los desafíos que plantea su entorno incluyendo la prevención de algunas patologías en edades posteriores, como es el caso de la diabetes tipo 1 y la obesidad.


During the first months of life, breast milk oligosaccharides (HMOs) stimulate development of the gastrointestinal tract in newborns and young infants; they modulate its metabolism and transport capabilities. Additionally, they exert prebiotic and antimicrobial activities and contribute to the development of the resident intestinal microbiota with a predominance of Bifidobacterium and Bacteroides and protect from colonization and infections by enteropathogens (bacteria, virus or parasites). It is highly probable that their activities extend beyond infancy and persist into adult life. HMOs stimulate the development of the innate and adaptive immune systems and decrease the risk of atopy/allergy. Their intake has been associated with a degree of protection against as necrotizing enterocolitis among premature infants. HMOs contribute to the long term adaptation and protection of newborn infants to unfavorable conditions of their environment and in this way may contribute to protect breastfed infants from type 1 diabetes and obesity.


Asunto(s)
Oligosacáridos/fisiología , Microbioma Gastrointestinal , Leche Humana , Oligosacáridos/inmunología
2.
Br J Nutr ; 98 Suppl 1: S74-9, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17922965

RESUMEN

Research on human milk oligosaccharides (HMO) began with the characterisation of their chemical structures and is now focused on the elucidation of their biological roles. Previously, biological effects could only be investigated with fractions or structures isolated from breast milk; consequently, clinical observations were limited to comparisons between outcomes from breast-fed infants and their formula-fed counterparts. In some cases, it was inferred that the observed differences were caused by the presence of HMO in breast milk. Presently, analytical techniques allow for the fast analysis of milk samples, thus providing insights on the inherent variability of specimens. In addition, methods for the synthesis of HMO have provided single structures in sufficient quantities to perform clinical studies with oligosaccharide-supplemented formulae. Furthermore, studies have been conducted with non-mammalian oligosaccharides with the purpose of assessing the suitability of these structures to functionally emulate HMO. Taken together, these developments justify summarising current knowledge on HMO to further discussions on efforts to emulate human milk in regard to its oligosaccharide content. The present account summarises published data and intends to provide an historical context and to illustrate the state of the field.


Asunto(s)
Fenómenos Fisiológicos Nutricionales del Lactante , Leche Humana/química , Oligosacáridos/fisiología , Medicina Basada en la Evidencia , Humanos , Lactante , Fórmulas Infantiles/química , Probióticos
3.
J Exp Bot ; 58(15-16): 4365-72, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18182438

RESUMEN

The related red seaweeds Gracilaria sp. from the eastern Mediterranean and Gracilaria chilensis from Chile were similar in their enzymatic inventory for halogenation. In both species, halogenation was dependent upon H(2)O(2) and thus driven by haloperoxidases. These could be inhibited with phosphate and reversibly inhibited with azide and were therefore apparently dependent upon vanadate. Both species generated in the first line bromoform and other brominated halocarbons. Gel electrophoresis under non-denaturating conditions demonstrated that both species expressed halogenating peroxidases. Elicitation of Gracilaria sp. with agar oligosaccharides resulted in marked increases in bromination, iodination, and chlorination. Production rates of volatile halocarbons and phenol red bromination both increased by a factor of eight, presumably due to increased availability for haloperoxidases of H(2)O(2) during the oxidative burst response. Elicitation of Gracilaria sp. also triggered a release of bromide ions through DIDS-sensitive anion channels, which allowed for some bromination in bromide-free medium. However, this effect was relatively limited. By contrast, agar oligosaccharide oxidation in G. chilensis did not increase halogenation. Obviously, agar oligosaccharide oxidation does not provide sufficient amounts of hypohalous acids for such increases, because it does not deliver H(2)O(2) at the active site of vanadium-dependent haloperoxidases. These results correlate with earlier findings that the agar oligosaccharide-elicited oxidative burst controls microorganisms while agar oligosaccharide oxidation does not.


Asunto(s)
Adaptación Psicológica , Gracilaria/enzimología , Halogenación/fisiología , Oligosacáridos/fisiología , Peroxidasas/metabolismo , Agar/metabolismo
5.
Cell Immunol ; 218(1-2): 87-94, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12470616

RESUMEN

Macrophages constitute one of the primary cellular mechanisms that impairs parasite invasion of host tissues. The phagocytic and microbicidal properties of these cells can be modulated by specific membrane receptors involved in cell-microorganism interactions. Gp43, the main antigen secreted by Paracoccidiodes brasiliensis (Pb), the causative agent of Paracoccidioidomycosis, is a high mannose glycoprotein. The role played by gp43 in the pathogenesis of the disease is not completely known. Here, we describe the influence of this molecule on the interaction between peritoneal murine macrophages and Pb. Phagocytosis of Pb, live or heat-killed, by adherent peritoneal cells from both, B10.A (susceptible) and A/Sn (resistant) mice, was evaluated. Addition of different concentrations of gp43 to the culture medium inhibited, in a dose-dependent pattern, phagocytosis of live or heat-killed Pb by peritoneal macrophages from both B10.A and A/Sn mice. Gp43 also inhibits phagocytosis of zymosan particles but did not interfere with the uptake of opsonized sheep red blood cells. It was also shown that both gp43 and heat-killed Pb have an inhibitory effect on the release of NO by zymosan stimulated macrophages. Finally, we demonstrated that gp43 inhibits the fungicidal ability of macrophages from both lineages. Based on these data, it is suggested that gp43 can be considered one of the evasion mechanisms for the installation of primary infection in susceptible hosts.


Asunto(s)
Antígenos Fúngicos/fisiología , Proteínas Fúngicas/fisiología , Glicoproteínas/fisiología , Macrófagos Peritoneales/efectos de los fármacos , Oligosacáridos/fisiología , Paracoccidioides/inmunología , Animales , Células Cultivadas/efectos de los fármacos , Células Cultivadas/fisiología , Medios de Cultivo Condicionados , Proteínas Fúngicas/farmacología , Glicoproteínas/farmacología , Peróxido de Hidrógeno/metabolismo , Inmunidad Innata/inmunología , Activación de Macrófagos/efectos de los fármacos , Macrófagos Peritoneales/fisiología , Masculino , Ratones , Ratones Endogámicos A , Óxido Nítrico/metabolismo , Oligosacáridos/farmacología , Fagocitosis/efectos de los fármacos
6.
Arch. latinoam. nutr ; Arch. latinoam. nutr;51(4): 332-339, Dec. 2001.
Artículo en Español | LILACS | ID: lil-331839

RESUMEN

Breast-feeding is the optimal mode of feeding for the normal full-term infant. Human milk composition knowledge has been basis for recommended dietary allowances for infants. Few studies about human milk carbohydrates have been done until the last decade. However, carbohydrates provide approximately 40-50 of the total energy content of breast milk. Quantitatively oligosaccharides are the third largest solute in human milk after lactose and fat. Each individual oligosaccharide is based on a variable combination of glucose, galactose, sialic acid, fucose and N-acetylglucosamine with many and varied linkages between them, thus accounting for the enormous number of different oligosaccharides in human milk. The oligosaccharides content in human milk varies with the duration of lactation, diurnally and with the genetic makeup of the mother. At present, a great interest in the roles of human milk oligosaccharides is raising. They act as a the soluble fibre in breast milk and their structure is available to act as competitive ligands protecting the breast-fed infant from pathogens and act as well as prebiotic. They may also act as source of sialic acid and galactose, essential for brain development. This is why today there is an increasing health and industrial interest in human milk oligosaccharides content, with the main purpose of incorporating them as new ingredients in infant nutrition.


Asunto(s)
Humanos , Animales , Femenino , Recién Nacido , Lactante , Desarrollo Infantil , Leche Humana , Oligosacáridos/fisiología , Lactancia Materna , Enfermedades del Recién Nacido/inmunología , Enfermedades del Recién Nacido/prevención & control , Leche , Leche Humana , Nutrición del Lactante/fisiología
7.
Arch Latinoam Nutr ; 51(4): 332-9, 2001 Dec.
Artículo en Español | MEDLINE | ID: mdl-12012557

RESUMEN

Breast-feeding is the optimal mode of feeding for the normal full-term infant. Human milk composition knowledge has been basis for recommended dietary allowances for infants. Few studies about human milk carbohydrates have been done until the last decade. However, carbohydrates provide approximately 40-50% of the total energy content of breast milk. Quantitatively oligosaccharides are the third largest solute in human milk after lactose and fat. Each individual oligosaccharide is based on a variable combination of glucose, galactose, sialic acid, fucose and N-acetylglucosamine with many and varied linkages between them, thus accounting for the enormous number of different oligosaccharides in human milk. The oligosaccharides content in human milk varies with the duration of lactation, diurnally and with the genetic makeup of the mother. At present, a great interest in the roles of human milk oligosaccharides is raising. They act as a the soluble fibre in breast milk and their structure is available to act as competitive ligands protecting the breast-fed infant from pathogens and act as well as prebiotic. They may also act as source of sialic acid and galactose, essential for brain development. This is why today there is an increasing health and industrial interest in human milk oligosaccharides content, with the main purpose of incorporating them as new ingredients in infant nutrition.


Asunto(s)
Desarrollo Infantil , Leche Humana/química , Oligosacáridos/fisiología , Animales , Lactancia Materna , Femenino , Humanos , Lactante , Fenómenos Fisiológicos Nutricionales del Lactante/fisiología , Recién Nacido , Enfermedades del Recién Nacido/inmunología , Enfermedades del Recién Nacido/prevención & control , Leche/química , Leche Humana/inmunología , Leche Humana/fisiología
8.
Sao Paulo; s.n; 1993. 109 p. ilus, tab.
Tesis en Portugués | LILACS | ID: lil-128256

RESUMEN

A interacao entre a laminina e gp120 140, uma proteina de celulas B16-F10, imunoquimicamente relacionada a alfa-6 beta-1 integrina, e dependente de oligossacaridios N-ligados presentes no receptor. Analise com lectinas de especificidades conhecidas permitiu concluir que gp120/140 e uma sialoglicoproteina, apresentando principalmente complexos antenarios, entre as estruturas N-ligadas. Ainda, foi possivel mostrar que gp120/140 apresenta residuos de alfa-galactose terminais. Por meio de tratamento com exoglicosidases, foi possivel mostrar que residuos alfa-gal presentes na cadeia alfa sao determinantes da interacao com laminina, em ensaios de ligand blotting. Estes residuos estao associados ao fenomeno de adesao celular. De outro lado, a cadeia beta-1, apresenta complexos tri- e tetra-antenarios, cuja sintese pode ser inibida indiretamente por swainsonina. Estes complexos parecem estar associados ao fenomeno de espalhamento celular. Mostrou-se ser possivel modular as funcoes de adesao e espalhamento mediadas por integrinas modificando-se o estado de glicolisacao de suas cadeias


Asunto(s)
Animales , Ratones , Femenino , Glicosilación , Integrinas/fisiología , Laminina/fisiología , Melanoma , Neoplasias por Tipo Histológico , Oligosacáridos/fisiología , Receptores de Superficie Celular , Sialoglicoproteínas/fisiología , Células Cultivadas , Glicoproteínas de Membrana , Metástasis de la Neoplasia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA